As of 2024-12-14, the Intrinsic Value of Nuvation Bio Inc (NUVB) is
-7.91 USD. This NUVB valuation is based on the model Peter Lynch Fair Value.
With the current market price of 2.63 USD, the upside of Nuvation Bio Inc is
-400.66%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-7.91 USD
Intrinsic Value
NUVB Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-7.91 - -7.91 |
-7.91 |
-400.66% |
| P/E |
(39.38) - (46.97) |
(43.10) |
-1738.6% |
| DDM - Stable |
(18.17) - (123.89) |
(71.03) |
-2800.7% |
| DDM - Multi |
(2.52) - (13.48) |
(4.25) |
-261.8% |
NUVB Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
885.18 |
| Beta |
2.73 |
| Outstanding shares (mil) |
336.57 |
| Enterprise Value (mil) |
863.57 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.62% |
| Cost of Debt |
5.00% |
| WACC |
5.65% |